GI Dynamics
IPORESET® Type 2 Diabetes Treatment - Morphic Medical
Boston, United States · Founded 2003 · $10.0M raised
- Headquarters
- Boston
- Founded
- 2003
- Business Model
- B2B
- Website
- morphicmedical.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series AAug 2019
- Rounds
- 1
About
Since its founding in 2003, Morphic Medical (formerly GI Dynamics) has developed RESET, the world's first endoscopically delivered device therapy for type 2 diabetes and obesity, designed to bridge the treatment gap between pharmaceuticals and surgery. The Boston-based company is approved for sale in the EU and UK and is currently enrolling U.S. patients in its STEP-1 clinical trial.
Summary
GI Dynamics is a Healthcare company based in Boston, United States, founded in 2003. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Aug 2019. Investors include Crystal Amber.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2019
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe